CX Institutional’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-47
| Closed | -$12K | – | 1184 |
|
|
2022
Q2 | $12K | Buy |
+47
| New | +$12K | ﹤0.01% | 928 |
|
|
2021
Q4 | – | Sell |
-91
| Closed | -$30K | – | 941 |
|
|
2021
Q3 | $30K | Buy |
91
+13
| +17% | +$4.29K | ﹤0.01% | 672 |
|
|
2021
Q2 | $24K | Buy |
78
+34
| +77% | +$10.5K | ﹤0.01% | 710 |
|
|
2021
Q1 | $14K | Buy |
44
+7
| +19% | +$2.23K | ﹤0.01% | 730 |
|
|
2020
Q4 | $12K | Buy |
37
+16
| +76% | +$5.19K | ﹤0.01% | 710 |
|
|
2020
Q3 | $6K | Sell |
21
-1
| -5% | -$286 | ﹤0.01% | 735 |
|
|
2020
Q2 | $5K | Buy |
+22
| New | +$5K | ﹤0.01% | 678 |
|
|
2019
Q4 | – | Sell |
-7
| Closed | -$1K | – | 783 |
|
|
2019
Q3 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 788 |
|
|
2019
Q1 | – | Sell |
-2
| Closed | -$1K | – | 833 |
|
|
2018
Q4 | $1K | Buy |
+2
| New | +$1K | ﹤0.01% | 525 |
|